Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,441 to 1,460 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mutational Landscape and Interaction of SARS-CoV-2 with Host Cellular Components. | Microorganisms | 2021 | 34576690 | PubTator, text mining | PubMed |
| Building Personalized Cancer Therapeutics through Multi-Omics Assays and Bacteriophage-Eukaryotic Cell Interactions. | Int J Mol Sci | 2021 | 34575870 | PubTator, text mining | PubMed |
| Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets. | Cells | 2021 | 34572076 | PubTator, text mining | PubMed |
| Type I Interferons in COVID-19 Pathogenesis. | Biology (Basel) | 2021 | 34571706 | PubTator, text mining | PubMed |
| Some viruses need to phase-separate to replicate. | EMBO J | 2021 | 34569635 | PubTator, text mining | PubMed |
| COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions. | Front Cell Infect Microbiol | 2021 | 34568087 | PubTator, text mining | PubMed |
| Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies. | Results Chem | 2021 | 34567959 | PubTator, text mining | PubMed |
| Addressing the 'hypoxia paradox' in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues. | Mol Med | 2021 | 34565332 | PubTator, text mining | PubMed |
| Screening for differentially expressed circRNAs in ischemic stroke by RNA sequencing. | BMC Neurol | 2021 | 34563140 | PubTator, text mining | PubMed |
| An atomistic model of the coronavirus replication-transcription complex as a hexamer assembled around nsp15. | J Biol Chem | 2021 | 34562452 | PubTator, text mining | PubMed |
| CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review. | Cell Mol Biol Lett | 2021 | 34556024 | PubTator, text mining | PubMed |
| Structural Analysis of SARS-CoV-2 ORF8 Protein: Pathogenic and Therapeutic Implications. | Front Genet | 2021 | 34552615 | PubTator, text mining | PubMed |
| Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin. | J Virol | 2021 | 34549987 | PubTator, text mining | PubMed |
| Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential. | Nat Commun | 2021 | 34548480 | PubTator, text mining | PubMed |
| SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response. | mBio | 2021 | 34544279 | PubTator, text mining | PubMed |
| Whole Genome Sequencing of SARS-CoV-2 Strains in COVID-19 Patients From Djibouti Shows Novel Mutations and Clades Replacing Over Time. | Front Med (Lausanne) | 2021 | 34540874 | PubTator, text mining | PubMed |
| Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment. | Blood Adv | 2021 | 34525182 | PubTator, text mining | PubMed |
| Liquid-liquid phase separation underpins the formation of replication factories in rotaviruses. | EMBO J | 2021 | 34524703 | PubTator, text mining | PubMed |
| SARS-CoV-2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms. | Mol Syst Biol | 2021 | 34519429 | PubTator, text mining | PubMed |
| Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies. | Heliyon | 2021 | 34518806 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=73